Tomer Kariv

Specializes in the development and commercialization of medical products

Develops innovative vaccines and immunotherapy products

Develops solutions for soft tissue fastening and attachment

Develops medicinal coatings for implantable medical devices

Develops medical devices to treat calcification related diseases

Operates as a biopharmaceutical company focused on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs

Develops bioactive feed supplements for infant formulas and animal feed

Develops and manufactures pharmaceutical products for ear indications

Engages in the research and development of insulin treatment methods

Develops and commercializes stomal management solutions

Develops a novel therapeutic platform to address chronic and hard-to-heal wounds, such as diabetic foot ulcers and venous leg ulcers

Develops gastrointestinal imaging devices

Develops and commercializes medical devices

Develops pharmaceutical products for prevention and treatment of neurodegenerative disorders

Develops therapeutic molecules for cancer, viral, and autoimmune diseases

Provides international business development services

Develops treatment options for people living with heart failure and cardiovascular disease

Develops disruptive products that allow physicians and patients to diagnose and monitor clinical parameters

Functions as a College/University

Operates as a clinical-stage biopharmaceutical company that develops novel genetic therapies

Engages in Manufacturing, sales and markets peripheral stents for treating and preventing obstructions

Develops medical devices

Develops innovative technology to treat obesity disease

Develops and commercializes medicines and therapies for bone metabolism, cardiology, neurology and rare diseases

Discovers and develops therapeutics for muscle diseases

Develops biopharmaceuticals

Develops AI-powered imaging platform that derives blood-flow physiology from standard coronary angiograms which helps clinicians for diagnostic and treatment decisions in coronary artery disease

Aliment Capital seeks investment opportunities in companies located across the globe. The firm targets companies operating across a broad range of sectors and industries. It provides financing for early, later and growth stage capital requirements.

Operates as an oncology company that specializes in cancer therapies

Develops a proprietary cancer drug

Develops clinical-stage medical diagnostics devices

Provides investment services

Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases

Operates as a biopharmaceutical company

Develops therapies and drugs for treatments of patients living with nonalcoholic steatohepatitis